Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Purpose of review Endometriosis is a gynecologic disorder that can lead to debilitating chronic pelvic pain and infertility. Gonadotropin-releasing hormone agonists (GnRHa) have emerged as a primary medical therapy for patients with symptomatic disease, but secondary hypoestrogenic side effects may limit compliance. Add-back therapy is a means of surmounting this problem. Recent findings Progestins such as norethindrone acetate may be administered with or without addition of low doses of estrogens to safely and effectively extend GnRHa therapy while minimizing side effects. Recent studies have demonstrated that the use of add-back enhances compliance and duration of therapy. The initiation of an add-back should not be deferred given evidence demonstrating an increase in vasomotor symptoms and bone loss if not administered concomitantly. The subset of adolescents with endometriosis who require GnRHa therapy should be administered an add-back, but require careful monitoring of bone mineral density. Summary Implementation of an appropriately selected add-back will significantly reduce hypoestrogenic side effects, enhance compliance, and allow for prolongation of therapy without interfering with the efficacy of GnRHa in treating symptomatic endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The association of GnRH agonists with hormonal add-back therapy prevents bone loss without decreasing their efficacy (Surrey et al., 2010).”
From When more is not better: 10 ‘don’ts’ in endometriosis management. An ETIC* position statement (2019) · cites this paper as Surrey et al., 2010
Citations
Cites
Aromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566
Laufer, M. R., Goitein, L., Bush, M., Cramer, D. W., & Emans, S. J. (1997) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/s1083-3188(97)70085-8 · Cited by 310
Epidemiology of endometriosis-associated infertility.
Wheeler, J. M. (1989) · PubMed · Cited by 270
Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis
Bulun, S., Cheng, Y.-H., Pavone, M., Xue, Q., Attar, E., Trukhacheva, E., Tokunaga, H., Utsunomiya, H., Yin, P., Luo, X., et al. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1242991 · Cited by 243
Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study
Hornstein, M. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00620-0 · Cited by 243
Self-citationProlonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1
SURREY, E. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)01945-2 · Cited by 169
Self-citationAdd-back therapy in the treatment of endometriosis-associated pain
Zupi, E., Marconi, D., Sbracia, M., Zullo, F., De Vivo, B., Exacustos, C., & Sorrenti, G. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.062 · Cited by 103
Sharpe-Timms, K. L., Keisler, L. W., McIntush, E. W., & Keisler, D. H. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00075-2 · Cited by 100
Moghissi, K. S., Schlaff, W. D., Olive, D. L., Skinner, M. A., & Yin, H. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00086-7 · Cited by 96
Meresman, G. F. (2003) · Human Reproduction · doi:10.1093/humrep/deg356 · Cited by 92
Cited by
Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview
Wang, L.-T., Chen, L.-R., & Chen, K.-H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065814 · Cited by 166
Pharmacologic therapies in endometriosis: a systematic review
Soares, S. R., Martínez‐Varea, A., Hidalgo‐Mora, J. J., & Pellicer, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.1120 · Cited by 164
Medical Treatment of Uterine Leiomyoma
Sabry, M., & Al-Hendy, A. A. (2012) · Reproductive Sciences · doi:10.1177/1933719111432867 · Cited by 163
Diamond, M. P., Carr, B. R., Dmowski, W. P., Koltun, W. D., O'Brien, C. F., Jiang, P. X., Burke, J., Jimenez, R., Garner, E. I. O., & Chwalisż, K. (2013) · Reproductive Sciences · doi:10.1177/1933719113497292 · Cited by 127
An update on the pharmacological management of endometriosis
Streuli, I., de Ziegler, D., Santulli, P., Marcellin, L., Borghese, B., Batteux, F., & Chapron, C. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.767334 · Cited by 104
Metadata
- Authors
- Surrey, E. S.
- Affiliations
- Colorado Center for Reproductive Medicine (US)
- Corresponding author
- Surrey, Eric S
- ORCID
- Surrey, Eric S
- Venue
- Current Opinion in Obstetrics & Gynecology
- Published
- 2010-08
- Volume
- 22
- Issue
- 4
- Pages
- 283-288
- ISSN
- 1040-872X (ISSN-L)
- OpenAlex
- W2036733694
- Cited by
- 64
- References
- 36
- Citations by year
- 2026: 3 · 2025: 4 · 2023: 5 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 7 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 6 · 2013: 6 · 2012: 6
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Obstetrics & Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- endometriosis, GnRH agonist, add-back therapy, norethindrone acetate, progestins, low-dose estrogen, medication adherence, vasomotor symptoms, bone loss, bone mineral density, adolescents, infertility, chronic pelvic pain
- MeSH terms
- Adolescent, Adult, Endometriosis, Estrogens, Female, Humans, Gonadotropin-Releasing Hormone, Osteoporosis, Progestins, Hormone Replacement Therapy, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? https://app.cochat.ai/papers/10.1097/gco.0b013e32833b35a7
- The paper
- Surrey, E. S. (2010). Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? Current Opinion in Obstetrics & Gynecology. https://doi.org/10.1097/gco.0b013e32833b35a7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.